AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAYNE PHARMA GROUP LTD

3.000

-0.180-5.66%

Volume:450.66K

Turnover:1.38M

Market Cap:245.67M

PE:14.45

High:3.170

Open:3.150

Low:2.990

Close:3.180

52wk High:6.500

52wk Low:2.040

Shares:81.89M

Float Shares:67.00M

Volume Ratio:1.34

T/O Rate:0.67%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.208

EPS(LYR):0.208

ROE:8.20%

ROA:-1.73%

PB:0.63

PE(LYR):14.45

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-1.36%

Capital Flow

Inflow:

Outflow:

News

Inhibitor Therapeutics Announces Annual Shareholder Meeting

Are Mayne Pharma Group (ASX:MYX) Shares Undervalued As Earnings Contract?

Simply Wall St.

Inhibitor Therapeutics Announces Annual Shareholder Meeting

Mayne Pharma Group Ltd-Non-Executive Director Appointment

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/MYX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":3,"timestamp":1789020720000,"preClose":3.18,"halted":0,"volume":450658,"delay":0,"changeRate":-0.05660377358490571,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81890887,"eps":0.207588,"marketStatus":"Closed","change":-0.18,"latestTime":"09-10 16:12:00 AEST","open":3.15,"high":3.17,"low":2.99,"amount":1384986,"amplitude":0.056604,"askPrice":3.13,"askSize":10000,"bidPrice":2.98,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.207588,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":3.18,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":1.342898,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MYX.AU","preClose":3.18,"auctionPrice":3.01,"auctionVolume":2361,"auctionTime":1789020602497,"referencePrice":3,"referenceTime":1789030800651,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020602497}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.73%","roe":"8.20%","lyrEps":0.207588,"volumeRatio":1.342898,"shares":81890887,"dividePrice":0,"high":3.17,"amplitude":0.056604,"preClose":3.18,"low":2.99,"week52Low":2.04,"pbRate":"0.63","psRate":"0.64","week52High":6.5,"institutionHeld":0,"latestPrice":3,"committee":-0.333333,"eps":0.207588,"divideRate":0,"volume":450658,"delay":0,"ttmEps":0.207588,"open":3.15,"prevYearClose":3.11,"prevWeekClose":3.11,"prevMonthClose":3.1,"prevQuarterClose":2.79,"fiveDayClose":3.11,"twentyDayClose":3.24,"sixtyDayClose":2.36,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666952370","title":"Inhibitor Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666952370","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666952370?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:16","pubTimestamp":1788902169,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics announces annual shareholder meetingInhibitor Therapeutics will hold its annual stockholders’ meeting virtually on Sept. 15, 2026.Stockholders will vote on matters set out in th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7Sc3qt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999014013.SGD","MYX.AU","BK4588","BK7096","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","IE00BKPKM429.USD","BK4112","SG9999014005.SGD","SG9999014021.USD","INTI","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","BK4139","IE00B64PRP62.GBP","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","LU2210149790.SGD","BK7508","IE00BN0W2T93.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701558","title":"Are Mayne Pharma Group (ASX:MYX) Shares Undervalued As Earnings Contract?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701558","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701558?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:38","pubTimestamp":1787942296,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group shares have slipped over the past week even after closing at A$3.01, leaving short term traders unimpressed. Yet the latest full year numbers tell a tougher story than the headline share price suggests. Revenue for FY26 came in at A$383.7m with underlying earnings before interest, tax, depreciation and amortisation of A$34.2m, both weaker than last year.\nThe real pivot is in the outlook. Consensus points to earnings decline over the next three years, even as the stock...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-myx/mayne-pharma-group-shares/news/are-mayne-pharma-group-asxmyx-shares-undervalued-as-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-myx/mayne-pharma-group-shares/news/are-mayne-pharma-group-asxmyx-shares-undervalued-as-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MYX","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660794482","title":"Inhibitor Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660794482","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660794482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:02","pubTimestamp":1786968142,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics announces annual shareholder meetingInhibitor Therapeutics schedules a virtual annual stockholder meeting on Sept. 15, 2026, held via the internet.Items include election of six ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLBW5kx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK4139","MYX.AU","INTI","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657594604","title":"Mayne Pharma Group Ltd-Non-Executive Director Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657594604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657594604?lang=en_us&edition=fundamental","pubTime":"2026-08-05 11:35","pubTimestamp":1785900920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUE2LT2TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MYX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":-0.013645}]}}